Fact checked by Nick Blackmer A new study suggests that Parkinson’s disease cases will rise worldwide by 112% by 2050.The ...

CYP46A1 knockdown relieves the spread of α-Syn pathology and the loss of dopaminergic ... in the progression of α-synuclein pathology in Parkinson’s disease, highlighting its potential as ...

Scientists have identified a rare genetic mutation in ITSN1 that increases the risk of Parkinson’s disease by up to tenfold, ...

A new study published in Cell Reports reveals a breakthrough discovery linking genetic variants in the gene ITSN1 to a ...

This recent study highlights the neuroprotective potential of TFE3, a transcription factor that plays a pivotal role in ...

This dual action—targeting both protein aggregation and mitochondrial dysfunction—positions TFE3 as a promising therapeutic candidate for Parkinson's disease. By bolstering the brain's natural ...

A team of scientists has revealed a breakthrough discovery, linking genetic variants in the gene ITSN1 to a significantly ...

The authors state, "Our findings indicate that the cholesterol 24-hydroxylase CYP46A1 plays a pivotal role in the progression of α-synuclein pathology in Parkinson's disease, highlighting its ...

The authors add, “Our findings indicate that the cholesterol 24-hydroxylase CYP46A1 plays a pivotal role in the progression of α-synuclein pathology in Parkinson’s disease, highlighting its ...